North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.470

-2.6%

11:25 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Stone who wrote (58)	11/4/1996 8:16:00 AM
From: Tom Stone	of 82

This was sent to Barron's via e-mail this am To the Editor: I find the latest Abelson column to be a blatant attempt to discredit a company and a stock to the benefit of short sellers. I believe it contains many incorrect and slanted statements. Abelson is obviously "in-bed" with Sturza, but Sturza must not have told him he has been recommending shorting NVX (North American Vaccine) since the stock was at 8 and is the largest loser by a big margin on Sturza's list of recommendations. I consider Abelson's failure to so mention that Sturza has recommended shorting since it was at 8 to be a major non-disclosure on the part of your columnist. As far as the facts go - Did Abelson or one of his associates consult with the FDA or anyone else in attendance at the meeting to determine what happened?? I know it was confusing, but I know of no one but Sturza coming to his conclusions that Abelson published. Did Sturza attend? Or was it one of his so-called Dr. advisors (cronies)? Sturza was said to be under investigation by authorities in recent years (see NY Times) and I can see why now. Is Abelson going to get tangled up in that same web? Why is that your Bill Alpert on page MW 8 tells a totally different story on NVX? I believe his remarks regarding NVX are THE FACTS. One final item - Was there a leak from Sturza concerning the Abelson column that was to appear the next day? I suspect that resulted in the negative stock activity on Friday since the stock had days before reacted to the FDA Panel meeting. I don't think Barron's would leak it, but STurza would. Hopefully, the damage to NVX in the market will be limited. I am a small holder so it will not hurt me, but I lose respect for Barron's when they publish such mistatements and associate with questionable characters. It is one thing to publish a negative story that is true and facts correct. It is another to publish one that contains blatant lies.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next